[The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients].
D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000410:Alanine Transaminase
Wpływ leczenia lamiwudyna na przebieg przewlekłego wirusowego zapalenia watroby typu B u biorców nerki allogenicznej.